SOLVAY SA (SOLB.BR)       87.44  +1.42 (+1.65%)

87.44  +1.42 (+1.65%)

BE0003470755 - Common Stock


Fundamental Rating

Taking everything into account, SOLB scores 4 out of 10 in our fundamental rating. SOLB was compared to 30 industry peers in the Chemicals industry. SOLB has a bad profitability rating. Also its financial health evaluation is rather negative. SOLB has a correct valuation and a medium growth rate.




Profitability

Profitability Rating


SOLB has a Return On Assets of 5.40%. This is comparable to the industry average of 5.84%.
SOLB has a Profit Margin of 9.43%. This is comparable to the industry average of 8.66%.

SOLB has a Piotroski-F score of 6.00. This indicates an average health and profitability for SOLB.
SOLB's Return On Equity of 12.45% is worse than the rest of the industry. The industry average Return On Equity is 17.99%.
VS Industry

ROA (5.4%) VS Industry: 41% outperformed.

-74.21
33.98

ROE (12.45%) VS Industry: 33% outperformed.

7.40
54.39

Profit Margin (9.43%) VS Industry: 57% outperformed.

-11,664.55
84.29

Valuation

Valuation Rating


The Price/Earnings Ratio is 7.76, which indicates a rather cheap valuation of SOLB.
The Forward Price/Earnings Ratio of 8.12 indicates a rather cheap valuation of SOLB.
When comparing the current price to the book value of SOLB, it is valued rather cheaply. It is trading at 0.96 times its book value.
Compared to an average industry price book ratio of 2.18, SOLB is valued rather cheaply. On top of this, SOLB is cheaper than 82% of the companies listed in the same industry.

Compared to an average industry Price/Earning Ratio of 9.40, SOLB is valued in line with its industry peers.
The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of SOLB to the average industry ratio of 5.81, SOLB is valued in line with its industry peers.
VS Industry

Price/Earnings (7.76) VS Industry: 58% outperformed.

40.97
1.00

Price/Book (0.96) VS Industry: 82% outperformed.

95.10
0.68

Enterprise Value/ EBITDA (5.08) VS Industry: 60% outperformed.

94.33
0.92

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 80.90% over the past year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Looking at the last year, SOLB shows a very strong growth in Revenue. The Revenue has grown by 30.04%.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.

SOLB shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 4.23% yearly.
SOLB is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 5.46% yearly.
SOLB shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 2.62% yearly.
Based on estimates for the next 5 years, SOLB will show a small growth in Revenue. The Revenue will grow by 5.17% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS4.23% 1.15% 80.9% 4.55% 3.59% 5.63% 5.46%
Revenue2.62% 0.4% 30.04% 16.67% 8.59% 7.35% 5.17%

Health

Health Rating


The Debt to Equity ratio for SOLB is way better than the industry averages.
SOLB has a Current Ratio of 1.29. This is a normal value and indicates that SOLB is financially healthy and should not expect problems in meeting its short term obligations.
SOLB has a Piotroski-F score of 6.00. This indicates an average health and profitability for SOLB.
Compared to an average industry Current Ratio of 1.89, SOLB is worse placed to pay its short term obligations than its industry peers. 87% of its industry peers have a better Current Ratio.

A Quick Ratio of 0.99 indicates that SOLB may have some problems paying its short term obligations.
When comparing the Quick Ratio of SOLB to the average industry Current Ratio of 1.18, SOLB is less able to pay its short term obligations than its industry peers.
SOLB has an Altman-Z score of 1.68. This is a bad value and indicates that SOLB is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of SOLB to the average industry Altman-Z score of 2.89, SOLB is less financially healthy than its industry peers. 90% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0.27) VS Industry: 72% outperformed.

1.29
-0.38

Quick Ratio (0.99) VS Industry: 27% outperformed.

0.60
8.68

Current Ratio (1.29) VS Industry: 13% outperformed.

0.61
8.68

Altman-Z (1.68) VS Industry: 10% outperformed.

-8.08
7.92

Dividend

Dividend Rating


Compared to an average S&P500 Dividend Yield of 2.39, SOLB pays a bit more dividend than the S&P500 average.
The dividend of SOLB is growing, but earnings are growing more, so the dividend growth is sustainable.
32.85% of the earnings are spent on dividend by SOLB. This is a low number and sustainable payout ratio.

SOLB has a Yearly Dividend Yield of 3.33%.
Compared to an average industry Dividend Yield of 3.11, SOLB has a dividend in line with its industry peers.
VS Industry

Dividend Yield (3.33%) VS Industry: 59% outperformed.

0.94
10.55
SOLB Daily chart

SOLVAY SA87.44

EBR:SOLB (8/10/2022, 5:35:30 PM)+1.42 (+1.65%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners N/A
Market Cap 9.06B Analysts 72
Valuation
PE 7.76 Fwd PE 8.12
PEG (NY) 1.7 PEG (5Y) 1.83
P/S 0.72 P/B 0.96
EV/EBITDA 5.08
Profitability
ROA 5.4% ROE 12.45%
PM 9.43 Asset Turnover 0.57
Growth
EPS 1Y 80.9% EPS 3Y 1.15%
EPS 5Y 4.23% EPS growth Q2Q 52.79%
EPS Next Y 4.55% EPS Next 2Y 3.59%
EPS Next 3Y 5.63% EPS Next 5Y 5.46%
Revenue growth 1Y 30.04% Revenue growth 3Y 0.4%
Revenue growth 5Y 2.62% Revenue growth Q2Q 41.82%
Revenue Next Year 16.67% Revenue Next 2Y 8.59%
Revenue Next 3Y 7.35% Revenue Next 5Y 5.17%
Health
Current Ratio 1.29 Quick Ratio 0.99
Altman-Z 1.68 F-Score 6
Debt/Equity 0.27
Dividend
Dividend Yield 3.33% Dividend Growth 0.88%
DP 32.85% Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext